Page last updated: 2024-11-13

lyngbyabellin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lyngbyabellin B: from the marine cyanobacterium Lyngbya majuscula; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID44558912
CHEMBL ID508049
MeSH IDM0374215

Synonyms (2)

Synonym
lyngbyabellin b
CHEMBL508049
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (24)

Assay IDTitleYearJournalArticle
AID377906Antimicrobial activity against Salmonella choleraesuis subsp. choleraesuis ATCC 14028 by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID502766Cytotoxicity against human HT-29 cells after 48 hrs by MTT assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Cytotoxic halogenated macrolides and modified peptides from the apratoxin-producing marine cyanobacterium Lyngbya bouillonii from Guam.
AID335478Effect on purified tubulin polymerization in human CA46 cells2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID335489Stimulation of rabbit muscle actin polymerization by centrifugation assay2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID377907Antimicrobial activity against Bacillus subtilis ATCC 6051 by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID335479Effect on microtubule cytoskeleton in human CA46 cells2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID377904Antimicrobial activity against Pseudomonas aeruginosa ATCC 10145 by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID335487Effect on actin cytoskeleton in rat kangaroo PtK2 cells assessed as hairy appearance at 10 uM after 24 hrs by immunofluorescence analysis2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID335218Antiproliferative activity against human CA46 cells after 24 hrs2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID377908Antimicrobial activity against Staphylococcus aureus ATCC 12600 by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID377901Toxicity against brine shrimp after 24 hrs2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID335484Effect on actin cytoskeleton in rat kangaroo PtK2 cells assessed as thickening in microfilament at 1.0 uM after 24 hrs by immunofluorescence analysis relative to untreated control2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID335477Cell cycle arrest in human CA46 cells assessed as accumulation at G2/M phase at 1.0 uM after 24 hrs using propidium iodide labeling by flow cytometry2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID502767Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2010Journal of natural products, Sep-24, Volume: 73, Issue:9
Cytotoxic halogenated macrolides and modified peptides from the apratoxin-producing marine cyanobacterium Lyngbya bouillonii from Guam.
AID377902Antimicrobial activity against Candida albicans ATCC 14053 at 100 ug/disk by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID335481Effect on actin cytoskeleton in rat kangaroo PtK2 cells assessed as increase in binucleated cells at 0.3 to 3 uM after 24 hrs by immunofluorescence analysis2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID377900Cytotoxicity against human LoVo cells2000Journal of natural products, Oct, Volume: 63, Issue:10
Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula.
AID335219Antiproliferative activity against rat kangaroo PtK2 cells after 48 hrs2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID377899Cytotoxicity against human KB cells2000Journal of natural products, Oct, Volume: 63, Issue:10
Isolation and structure of the cytotoxin lyngbyabellin B and absolute configuration of lyngbyapeptin A from the marine cyanobacterium Lyngbya majuscula.
AID377905Antimicrobial activity against sEscherichia coli ATCC 11775 by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID377903Antimicrobial activity against Candida albicans ATCC 14053 at 10 ug/disk by disk agar plate assay2000Journal of natural products, Oct, Volume: 63, Issue:10
Lyngbyabellin B, a toxic and antifungal secondary metabolite from the marine cyanobacterium Lyngbya majuscula.
AID335482Effect on actin cytoskeleton in rat kangaroo PtK2 cells assessed as increase in binucleated cells at 1 to 10 uM after 24 hrs by by immunofluorescence analysis2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID335483Effect on actin cytoskeleton in rat kangaroo PtK2 cells assessed as thickening in microfilament at 0.3 uM after 24 hrs by immunofluorescence analysis relative to untreated control2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
AID335486Effect on actin cytoskeleton in rat kangaroo PtK2 cells assessed as hairy appearance at 3 uM after 24 hrs by immunofluorescence analysis2002Journal of natural products, Jun, Volume: 65, Issue:6
Structure and absolute stereochemistry of hectochlorin, a potent stimulator of actin assembly.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.58

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.58 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.58)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]